In this study, we investigate the regulatory mechanism of BPI in the LPS-LBP-CD14 signaling pathway associated with cognitive impairment after diabetes, and find a promising clinical therapy for diabetes with cognitive impairment. This evidence concerns the gene LBP and diabetes mellitus.